本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Precision Biosciences Inc

5.33
-0.1700-3.09%
盘后5.330.00000.00%17:06 EDT
成交量:6.95万
成交额:37.35万
市值:5,586.87万
市盈率:5.13
高:5.68
开:5.49
低:5.16
收:5.50
数据加载中...

公司资料

公司名字:
Precision Biosciences Inc
交易所:
NASDAQ
成立时间:
2006
员工人数:
108
公司地址:
302 East Pettigrew Street,Suite A-100,Durham,North Carolina,United States
邮编:
27701
电话:
传真:
480 393 5553
简介:
Precision BioSciences, Inc.在特拉华州注册成立。该公司是一家先进的基因编辑公司,利用新型专有ARCUS平台开发用于复杂基因编辑的体内基因编辑疗法,包括基因消除、插入和切除。

董事

名称
职位
Matthew Kane
President, Chief Executive Officer and Director
Derek Jantz
Chief Scientific Officer and Director
Geno Germano
Independent Director
Kevin Buehler
Interim Chair of the Board, Independent Director
Raymond Schinazi
Independent Director
Shalini Sharp
Independent Director
Tony Yao
Independent Director

股东

名称
职位
Fayaz Khazi
Chief Executive Officer, Elo Life Systems
Matthew Kane
President, Chief Executive Officer and Director
David Thomson
Chief Operating Officer
Abid Ansari
Chief Financial Officer
Christopher Heery
Chief Medical Officer
Dario Scimeca
General Counsel and Secretary
Derek Jantz
Chief Scientific Officer and Director